Paloma Partners’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-7,780	Closed	-$239K	–	1879
2019 Q2	$239K	Buy	+7,780	New	+$239K	﹤0.01%	1185